Post

New research · Hematology
Genome medicine · 23h
AI / informaticsGenome medicine · 2026

clinTALL: machine learning-driven multimodal subtype classification and treatment outcome prediction in pediatric T-ALL.

Lukas Stoiber, Željko Antić, Stefano Rebellato … Anke Katharina Bergmann
Read paper
HematologyAI / informatics

Machine learning model accurately predicts induction failure in pediatric T-lineage acute lymphoblastic leukemia.

clinTALL: machine learning-driven multimodal subtype classification and treatment outcome prediction in pediatric T-ALL.

Lukas Stoiber et al. · Genome medicine · 2026
Background

Childhood T-lineage acute lymphoblastic leukemia (T-ALL) is an aggressive hematologic malignancy with poor prognosis.

Methods

Here, we present clinTALL, a deep learning based multi-task pipeline for pediatric T-ALL subtype classification and treatment outcome estimation.

n = 1309 pediatric T-ALL samples
C-index = 96.0%
Results
The model accurately predicted when initial leukemia treatment would not work
n = 1309 pediatric T-ALL samples
More results

We observed that the transcriptomic-only model achieved superior single-modality results, with 92.2% accuracy for subtype prediction and a 65.9% concordance index (C-index) for event-free survival (EFS) in a cross-validation setup.

More results

Integrating all data modalities maintained high subtype classification accuracy (91.7%) and improved the overall concordance index for EFS estimation to 67.5%.

We validated molecular subtype predictions on an internal dataset of 120 pediatric T-ALL samples and obtained an accuracy of 81.8%.

“
Conclusion · 1 of 2

Together, our machine learning-based framework allows for automated, accurate subtype classification and treatment outcome inference using multimodal input data, advancing precision risk stratification for pediatric T-ALL.

Conclusion · 2 of 2

The full source code of clinTALL is available on GitHub ( https://github.com/UKWgenommedizin/clinTALL ).

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
Case-control
AUC = 0.94
CXCL9 levels accurately distinguish acute myeloid leukemia that resists treatment from remission
Cohort Study
AUC 0.939
Neutrophil-to-lymphocyte ratio is excellent at predicting who will get lung problems after bypass surgery
Guideline
>95%
most Hairy Cell Leukemia patients have a specific gene change causing their cancer
AI / Informatics
10.92%
Paroxysmal nocturnal haemoglobinuria was diagnosed in high-risk patients referred for testing by AI screening
Cohort Study
49%
Nearly half of patients had problems 30 days after spleen removal for blood cancer
Cohort Study
OR: 0.89
GLP-1RA users had slightly lower odds of Hodgkin's lymphoma than DPP-4i users
Cohort Study
adjusted hazard ratio 1.917
Patients with leukoerythroblastosis had a 1.9-fold higher hazard of 90-day death.
Cohort Study
OR 3.95
flexible sigmoidoscopy makes it almost 4 times more likely to find gastrointestinal GvHD